Recombinant Mouse ATP-sensitive inward rectifier potassium channel 8 (Kcnj8)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Mouse ATP-Sensitive Inward Rectifier Potassium Channel 8 (KCNJ8)

Recombinant Mouse ATP-sensitive inward rectifier potassium channel 8 (KCNJ8), also known as Kir6.1, is a protein encoded by the KCNJ8 gene. It functions as a subunit of ATP-sensitive potassium (K<sub>ATP</sub>) channels, which regulate cellular electrical activity by coupling metabolic states to membrane potential. These channels are critical in cardiovascular, immune, and metabolic systems. Recombinant KCNJ8 is produced via laboratory methods (e.g., bacterial or mammalian cell expression systems) for research or therapeutic applications .

Cardiovascular System

KCNJ8/Kir6.1 regulates vascular tone and cardiac adaptation to metabolic stress. Defects are linked to:

  • J-Wave Syndromes: Gain-of-function mutations (e.g., S422L) increase arrhythmia risk .

  • Sudden Infant Death Syndrome (SIDS): Loss-of-function mutations (e.g., E332del, V346I) disrupt cardiac repolarization .

  • Hypertension: Kir6.1 deficiency in smooth muscle elevates blood pressure .

Immune Function

KCNJ8 is critical for NK cell maturation and degranulation. NK-cell-specific Kcnj8 ablation reduces mature CD27<sup>−</sup>/CD11b<sup>+</sup> NK cells and alters cytokine signaling pathways .

Metabolic Regulation

In pancreatic β-cells, KCNJ8/Kir6.1 forms K<sub>ATP</sub> channels with SUR1, linking glucose metabolism to insulin secretion .

Antibody-Based Detection

Mouse monoclonal antibodies (e.g., [S366-60] or [N366/60]) target the C-terminal region (aa 300–424) of recombinant KCNJ8. These are validated for Western blot (WB), immunocytochemistry (ICC), and immunofluorescence (IF) .

AntibodyTarget RegionApplicationsSpecies Reactivity
[S366-60]aa 300–C-terminusWB, ICC/IFHuman, Rat
[N366/60]aa 306–424 (C-terminus)WB, IHCMouse, Rat

Genetic Models

  • Kcnj8 Knockout Mice: Exhibit spontaneous ST-segment elevation, atrioventricular block, and sudden death, mimicking human arrhythmias .

  • NK-Cell-Specific Kcnj8 Ablation: Impairs NK cell development and cytokine signaling .

Key Mutations and Functional Impacts

MutationEffectAssociated ConditionSource
S422LGain-of-function (reduced ATP sensitivity)J-wave syndromes, atrial fibrillation
E332delLoss-of-function (channel inactivation)SIDS, cardiac arrest
V346ILoss-of-functionSIDS, arrhythmias
C176SGain-of-functionCantú syndrome (hypertrichosis)

Research Findings and Therapeutic Implications

  • Cardiac Arrhythmias: The S422L mutation increases I<sub>K-ATP</sub> current, shortening action potential duration and predisposing to ventricular fibrillation .

  • Immunological Defects: Kcnj8 KO mice show exaggerated susceptibility to LPS and impaired NK cell maturation .

  • Diagnostic Potential: Genetic screening for KCNJ8 variants is emerging for SIDS and channelopathies .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify any format requirements in your order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
Note: While the tag type is determined during production, please specify your required tag type for preferential development.
Synonyms
Kcnj8; ATP-sensitive inward rectifier potassium channel 8; Inward rectifier K(+ channel Kir6.1; Potassium channel, inwardly rectifying subfamily J member 8; uKATP-1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-424
Protein Length
Full length protein
Species
Mus musculus (Mouse)
Target Names
Target Protein Sequence
MLARKSIIPEEYVLARIAAENLRKPRIRDRLPKARFIAKSGACNLAHKNIREQGRFLQDI FTTLVDLKWRHTLVIFTMSFLCSWLLFAIMWWLVAFAHGDIYAYMEKGTMEKSGLESAVC VTNVRSFTSAFLFSIEVQVTIGFGGRMMTEECPLAITVLILQNIVGLIINAVMLGCIFMK TAQAHRRAETLIFSRHAVIAVRNGKLCFMFRVGDLRKSMIISASVRIQVVKKTTTPEGEV VPIHQQDIPVDNPIESNNIFLVAPLIICHVIDKRSPLYDISATDLANQDLEVIVILEGVV ETTGITTQARTSYIAEEIQWGHRFVSIVTEEEGVYSVDYSKFGNTVRVAAPRCSARELDE KPSILIQTLQKSELSHQNSLRKRNSMRRNNSMRRNNSIRRNNSSLMVPKVQFMTPEGNQC PSES
Uniprot No.

Target Background

Function

This G protein-regulated potassium channel belongs to the inward rectifier potassium channel family. These channels exhibit a greater permeability to potassium influx than efflux. Their voltage dependence is modulated by extracellular potassium concentration; increasing external potassium shifts the channel opening voltage range to more positive potentials. Inward rectification is primarily attributed to intracellular magnesium blockage. The channel is susceptible to blockade by external barium.

Gene References Into Functions
  1. Endotoxemia enhances pulmonary Kir6.1 gene and protein expression. PMID: 29433570
  2. miR-20 may regulate myocardial ischemia by targeting KATP subunit Kir6.1, accelerating cell apoptosis. PMID: 28786072
  3. The S422L mutation in the KCNJ8 gene is not a direct cause of J wave syndrome. PMID: 28928055
  4. Findings indicate the incorporation of native Kir6.1 subunits into pancreatic KATP channels and their contribution to insulin secretion control. PMID: 27956473
  5. Data support the existence of an endothelial KATP channel containing Kir6.1, influencing coronary vascular reactivity and offering ischemia-reperfusion protection. PMID: 28893911
  6. Similar to Kir6.1(-/-) myocytes, Kir6.1 gain-of-function myocytes exhibit resistance (reduced volume derangement) to cardioplegic stress. PMID: 27884343
  7. K(ATP) channel gain-of-function increases myocardial L-type Ca(2+) current and contractility in Cantu syndrome. PMID: 27247394
  8. Kcnj8 mutations underlie heart conduction abnormalities in Cantu syndrome. PMID: 26142302
  9. Exercise training upregulates Kir6.1, improves tissue oxygenation recovery, and protects against ischemia/reperfusion injury. PMID: 25474642
  10. Findings suggest that the vascular KATP channel Kcnj8 provides organ protection in diabetic conditions. PMID: 25825210
  11. Kir6.1 absence does not affect myocyte contractile properties during stress, suggesting improved myocyte stress tolerance via an unknown mechanism. PMID: 25872691
  12. SUR2B subunit sulfhydration modifies Kir6.1 subunit tyrosine nitration within the KATP channel complex. PMID: 25552582
  13. Kir6.1 underlies the vascular smooth muscle KATP channel, playing a crucial role in vascular reactivity and blood pressure regulation. PMID: 24914196
  14. Native K(ATP) channels in mouse vas deferens myocytes are a heterocomplex of K(IR)6.1 channels and SUR2B subunits. PMID: 24117345
  15. Kir6.1 knockdown exacerbates cerebral ischemia-reperfusion-induced brain damage. PMID: 23663330
  16. A potential Cx43-Kir6.1 interaction enhances understanding of their roles in ischemia/hypoxia preconditioning. PMID: 22960107
  17. K(ATP) channel deregulation significantly impacts innate antiviral immunity in the heart. PMID: 21719711
  18. Gene disruption causes Prinzmetal angina in knockout mice. PMID: 11984590
  19. Inflammation upregulates Kir 6.1 expression (almost 22-fold) and downregulates SUR2B expression (threefold). Decreased colonic motility during inflammation may relate to altered Kir 6.1 and SUR2B transcriptional regulation. PMID: 14962845
  20. The Kir6.1-containing K(ATP) channel, linking vasoreactivity with metabolic demand, is crucial for cardiovascular tolerance during endotoxic shock. PMID: 17077304
  21. Functional Kir6.1 channels regulate glutamate release at CA3 synapses in generating epileptic seizures. PMID: 17883401
  22. A null Kcnj8 allele (encoding Kir6.1) results in increased susceptibility to infection; Kir6.1 combines with SUR2 to form an ATP-sensitive potassium channel (K(ATP)) expressed in coronary arteries. PMID: 18026101
  23. Assigning Kir6.1 a role in mitoK(ATP) based solely on immunoreactivity is premature. PMID: 18068667
  24. SUR2 and Kir6.1 mRNAs are most abundant in ventricular fibroblasts. PMID: 19166858
Database Links

KEGG: mmu:16523

STRING: 10090.ENSMUSP00000032374

UniGene: Mm.1482

Protein Families
Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ8 subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is Kcnj8 and what is its significance in physiological systems?

Kcnj8 encodes Kir6.1, a critical component of ATP-sensitive potassium (KATP) channels. These channels function as important regulators of vascular tone and cardiac adaptive responses to metabolic stress . Structurally, Kcnj8-encoded Kir6.1 channels form functional complexes with sulfonylurea receptor subunits, creating channels that sense cellular metabolic states.

In mouse models, Kcnj8 deficiency causes significant cardiac abnormalities including spontaneous ST segment elevation followed by atrioventricular block, leading to premature sudden death . Additionally, Kcnj8-deficient mice exhibit maladaptive systemic inflammatory responses to infection, resulting in heightened vulnerability to endotoxin-mediated stress .

How is Kcnj8 expression distributed across immune cell populations?

Kcnj8 demonstrates a highly specific expression pattern within immune cell subsets:

Cell PopulationKcnj8 ExpressionNotes
Splenic CD27-/CD11b+ NK cellsHighMost pronounced in mature NK cells
Cytotoxic CD8+ T cellsStrong upregulationFollowing viral infection
Total splenocytes~4% positiveDetermined by RNAscope analysis
NK cells (Ncr1+)11.1% positiveOnly subset of NK cells express Kcnj8
CD3+ T cells~9-11% positiveSimilar proportion to NK cells
Macrophages~9-11% positiveSimilar proportion to NK cells

The heterogeneous expression pattern, particularly the enrichment in mature NK cells, suggests that Kcnj8 plays specialized roles in specific immune cell subpopulations rather than functioning universally across all immune cells .

What are optimal approaches for detecting Kcnj8 expression in tissue samples?

Multiple complementary techniques can be employed to comprehensively analyze Kcnj8 expression:

  • RT-PCR: Provides reliable detection of Kcnj8 mRNA in isolated cell populations. This method has been successfully used to confirm expression in both mouse NK cells and brain tissue .

  • RNAscope Analysis: Offers spatial visualization of Kcnj8 transcripts within intact tissue sections. This technique revealed that approximately 4.4% of cells in mouse spleen express Kcnj8, with specialized distribution across immune cell subtypes .

  • Single-cell RNA Sequencing (scRNA-seq): Enables high-resolution mapping of expression patterns at single-cell resolution. Analysis of NK cells isolated from mouse spleens using negative selection identified 16 distinct cell clusters, with Kcnj8 expression varying significantly across these populations .

  • Bulk RNA Sequencing: Valuable for comparative analysis between wild-type and gene-modified samples. This approach revealed specific transcriptional changes in NK cells following Kcnj8 deletion .

For optimal results, researchers should employ multiple detection methods to overcome the limitations of any single approach, particularly when studying genes with restricted expression patterns like Kcnj8.

What expression vectors and systems are recommended for recombinant Kcnj8 studies?

For heterologous expression studies, the following expression system has been documented:

  • Vector: pCMV6-Entry vector containing Kcnj8 (NM_008428) with C-terminal Myc-DDK tag

  • Selection Markers: Kanamycin (25 μg/mL) for E. coli; Neomycin for mammalian cells

  • Expression System: COS-1 cells have been successfully used for co-expression of Kcnj8 with SUR2A to form functional channels

Important Consideration: When conducting functional studies, Kcnj8 should be co-expressed with SUR2A to form complete and physiologically relevant KATP channel complexes . Expression of Kcnj8 alone may not yield functional channels for electrophysiological characterization.

What electrophysiological approaches are most effective for assessing Kcnj8 channel function?

The gold standard for functional characterization of Kcnj8 channels is whole-cell patch-clamp electrophysiology. This approach allows direct measurement of channel activity under controlled conditions .

Methodological Protocol:

  • Co-express Kcnj8 with SUR2A in a suitable mammalian cell line (e.g., COS-1)

  • Perform whole-cell patch-clamp recordings

  • Activate channels using pharmacological agents such as pinacidil

  • Measure current-voltage relationships across a range of membrane potentials (typically from -20 mV to +40 mV)

  • Compare experimental conditions using standardized electrophysiological parameters

This approach has successfully demonstrated functional differences between wild-type Kcnj8 and mutant channels, revealing that loss-of-function mutations can reduce pinacidil-activated KATP currents by 40-68% compared to wild-type channels .

What role does Kcnj8 play in NK cell development and maturation?

  • Expression Pattern: Kcnj8 is predominantly expressed in mature CD27-/CD11b+ NK cells, suggesting stage-specific functions .

  • Developmental Impact: NK cell-specific Kcnj8 knockout results in:

    • ~50% reduction in the most mature CD27-/CD11b+ NK cell population

    • Corresponding increase in immature CD27+/CD11b- populations

    • Reduction in mature KLRG1+ NK cells

  • Transcriptional Effects: Differential gene expression analysis in Kcnj8-deficient NK cells revealed altered expression of genes involved in:

    • Phospholipase C activity

    • Cytokine production

    • JAK-STAT signaling

    • Key developmental regulators (Il7r, Ltb, Kit)

These findings collectively demonstrate that Kcnj8 functions as a cell-intrinsic regulator of NK cell developmental progression, particularly affecting the transition to terminal maturation stages .

What mutation detection methods are recommended for comprehensive Kcnj8 analysis?

A systematic approach for Kcnj8 mutation screening includes:

  • DNA Extraction: Using standardized kits such as Puregene DNA Isolation Kit

  • Mutation Screening Pipeline:

    • PCR amplification of coding regions

    • Denaturing high-performance liquid chromatography (DHPLC) for variant detection

    • Direct DNA sequencing of regions with detected variants

  • PCR Conditions: For optimal results, the following parameters have been validated:

Primer PairForward PrimerReverse PrimerProduct Size (bp)MgCl₂Annealing TempDHPLC Temp (°C)
KCNJ8-2bCCATCACGGTTTTGATTCTCCAGAAAAATGTTATTGCTCTCG3262mMA5860, 56.4-66.4
KCNJ8-2cGGTTCCTATTCACCAACTGGGCACCGTGGAGCAGCTAC3402mMA5860, 58-68
  • Control Population Screening: For proper variant interpretation, mutations should be screened against appropriate ethnic-matched reference populations (e.g., 400 white and 200 black reference alleles) .

This comprehensive approach enables reliable detection of both common and rare variants in the Kcnj8 coding sequence.

How do Kcnj8 mutations affect channel function and what are their physiological consequences?

Kcnj8 mutations can significantly alter channel function, with important physiological implications:

Loss-of-Function Mutations:

  • E332del (in-frame deletion): Reduces pinacidil-activated KATP current by 45-68%

  • V346I (missense mutation): Reduces pinacidil-activated KATP current by 40-57%

  • Both mutations localize to Kir6.1's C-terminus and affect conserved residues

  • These mutations have been identified in sudden infant death syndrome (SIDS) cases

Gain-of-Function Mutations:

  • S422L: Associated with idiopathic ventricular fibrillation with prominent early repolarization

These findings demonstrate that both loss and gain of Kcnj8 function can lead to pathological consequences, highlighting the critical importance of precisely regulated KATP channel activity for normal physiology.

What knockout strategies have proven effective for studying Kcnj8 function in specific cell types?

Multiple complementary genetic approaches have been successfully employed:

  • Constitutive NK Cell-Specific Knockout: Used to study baseline developmental phenotypes in bone marrow and spleen NK cells

  • Tamoxifen-Inducible NK Cell-Specific Knockout: Enables temporal control of gene deletion, allowing for differentiation between developmental and functional effects

  • Knockout Validation: RNA sequencing confirms successful targeting strategy with specific depletion of reads mapping to exon 2 of Kcnj8 in knockout cells

The combination of these approaches provides a comprehensive toolkit for dissecting the cell-type-specific roles of Kcnj8 in complex physiological systems.

What pharmacological tools can be used to modulate Kcnj8 channel activity in experimental systems?

Several pharmacological agents facilitate precise manipulation of Kcnj8-containing KATP channels:

AgentActionApplication
PinacidilKATP channel openerActivates channels for functional assessment
GlibenclamideKATP channel blocker (sulfonylurea)Inhibits channel activity; mitigates proinflammatory cytokine production
PNU-37883ASelective Kir6.1 channel blockerProvides subtype-specific inhibition
TRAM-34Used in experimental protocolsControl agent in NK cell studies

These pharmacological tools enable selective modulation of channel activity in both in vitro and in vivo experimental systems, facilitating functional characterization of Kcnj8 in diverse physiological contexts.

How do findings from mouse Kcnj8 studies translate to human disease mechanisms?

Research on mouse Kcnj8 has provided valuable insights into human pathophysiology:

  • SIDS Association: Loss-of-function mutations in human KCNJ8 (E332del and V346I) have been identified in SIDS cases, suggesting impaired KATP channel function may contribute to sudden death in infancy .

  • Cardiac Arrhythmias: The S422L gain-of-function mutation in KCNJ8 has been linked to idiopathic ventricular fibrillation with early repolarization, identified in multiple patients .

  • Inflammatory Response: Findings that glibenclamide (KATP channel blocker) mitigates proinflammatory cytokine production in neutrophils from diabetic patients align with mouse studies showing exaggerated LPS susceptibility in Kcnj8-deficient animals .

  • Infection Susceptibility: Mouse studies revealing increased vulnerability to infections in Kcnj8-deficient animals (including the "mayday" mutant with MCMV susceptibility) suggest potential roles for KATP channels in human infectious disease responses .

These translational connections highlight the relevance of mouse Kcnj8 research for understanding human pathophysiology and potential therapeutic interventions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.